|
MIDN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.119400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.365800E-01 |
| Normal-vs-Stage2 |
7.075600E-02 |
| Normal-vs-Stage3 |
1.357760E-01 |
| Normal-vs-Stage4 |
5.312200E-01 |
| Stage1-vs-Stage2 |
9.735500E-02 |
| Stage1-vs-Stage3 |
1.239560E-01 |
| Stage1-vs-Stage4 |
9.427600E-01 |
| Stage2-vs-Stage3 |
4.520800E-01 |
| Stage2-vs-Stage4 |
1.777160E-01 |
| Stage3-vs-Stage4 |
3.222800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.345400E-01 |
| Normal-vs-AfricanAmerican |
6.549600E-01 |
| Normal-vs-Asian |
6.812800E-01 |
| Caucasian-vs-AfricanAmerican |
3.592400E-01 |
| Caucasian-vs-Asian |
9.204800E-01 |
| AfricanAmerican-vs-Asian |
4.184800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.224400E-01 |
| Normal-vs-Female |
3.781400E-01 |
| Male-vs-Female |
1.031610E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.947800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.146450E-01 |
| Normal-vs-Age(61-80Yrs) |
6.608500E-02 |
| Normal-vs-Age(81-100Yrs) |
4.633400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.118000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.075600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.010000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.274200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.704400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.294600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.739690E-02 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
5.660300E-02 |
| Classical-VS-Normal |
8.613800E-01 |
| Tall-VS-Follicular |
1.585230E-04 |
| Tall-VS-Other |
6.138600E-01 |
| Tall-VS-Normal |
1.664760E-01 |
| Follicular-VS-Other |
1.019180E-01 |
| Follicular-VS-Normal |
9.62159999999823E-05 |
| Other-VS-Normal |
1.229160E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.306300E-02 |
| Normal-vs-N1 |
7.213600E-01 |
| N0-vs-N1 |
3.791800E-04 |
|
|
